Finance

Lists
6Q40:FRA
Mink Therapeutics Inc
€7.35
-1.34%
(-0.100) 1D
Oct 20, 3:25:01 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6Q40...
Open
€8.35
High
€8.35
Low
€7.35
Mkt. cap
48.78M
Avg. vol.
0.00
Volume
0.00
52-wk high
€12.30
52-wk low
€6.60
No. of employees
15
Open
€8.35
High
€8.35
Low
€7.35
Mkt. cap
48.78M
Avg. vol.
0.00
Volume
0.00
52-wk high
€12.30
52-wk low
€6.60
No. of employees
15
News stories
From web sources and news partners
About Mink Therapeutics Inc
CEO-
Employees15
Founded2017
Headquarters-
SectorBiotechnology
Websiteminktherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.14M
1.51M
1.20M
1.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.85M
1.76M
1.68M
1.33M
Operating expense
3.18M
2.71M
2.88M
3.22M
Total operating expenses
3.18M
2.71M
2.88M
3.22M
Operating income
-3.18M
-2.71M
-2.88M
-3.22M
Other non operating income
240.73K
-7.87K
58.58K
-
EBT including unusual items
-2.89M
-2.60M
-2.74M
-3.13M
EBT excluding unusual items
-2.89M
-2.60M
-2.74M
-3.13M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
193.92K
-571.10K
-
-
Net income
-2.89M
-2.60M
-2.74M
-3.13M
Net profit margin
-
-
-
-
Earnings per share
-0.65
-0.56
-0.57
-0.62
Interest and investment income
55.15K
111.23K
80.83K
72.88K
Interest expense
-
-
-
-
Net interest expenses
55.15K
111.23K
80.83K
72.88K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.14M
-2.67M
-2.85M
-3.18M
Gain or loss from assets sale
2.19K
509.00
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps